维普期刊资源整合服务平台（V6.5）

74篇 您的检索式：作者名="Ravandi S"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	The influence of solvent type and polymer concentration on the physical properties of solid state polymerized PA 66 nanofiber yarn显示文摘	SANATGAR Razieh Hashemi BOHANI Sedigheh RAVANDI S A H		0，，3：	1
2	Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System显示文摘	Kantarjian H O'Brien S Ravandi F		0，，：	1
3	Cotton yarn engineering via fuzzy least squares regression显示文摘	FATTAHI S TAHERI S M RAVANDI H	2012	Fibers and Polymers2012，13，3：	1
4	Clinical features of de novo acute myeloid leukemia with concurrent DNMT3A, FLT3 and NPM1 mutations显示文摘	Loghavi S Zuo Z Ravandi F	2014	J Hematol Oncol2014，7，1：	1
5	Intensive chemotherapy does not benefit most older patients( age 70 years or older)with acute myeloid leukemia显示文摘	Kantariian H Ravandi F O'Brien S	2010	Blood2010，116，22：	1
6	A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myeiodysplastic syndrome显示文摘	Faderl S Ravandi F Huang X	2008	Blood2008，112，5：	1
7	Results of thehyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimen in elderly patients with acute lymphocytic leukemia显示文摘	O'BRIEN S THOMAS D A RAVANDI F	2008	Cancer2008，113，8：	1
8	Fourier transform analysis of plain woven fabric appearance显示文摘	Ravandi S A H Thorium K	1995	Textile ResearchJourna1995，65，：	1
9	Alemtuzumab 显示文摘	Ravandi F O'Brien S	2005	Expert Rev Anticancer Ther2005，5，1：	1
10	A randomized study of Clofarabine versus Clofarabine plus low-dose Cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodysplastic syndrome 显示文摘	Faderl S Ravandi F Huang X	2008	Blood2008，112，5：	1
11	Eosinophilia in the ethmoid mucosa and its relationship to the severity of inflammation in chronic rhinosinusitis 显示文摘	SZUCS E RAVANDI S GOOSSENS A	2002	Am J Rhinol2002，16，：	1
12	Rapid detection and quantitation of BRAF mutations in hairy cell leukemia using a sensitive pyrosequencing assay显示文摘	Verma S Greaves WO Ravandi F	2012	Am J Clin Pathol2012，138，1：	1
13	Phase I trial of AT9283,a multitargeted kinase inhibitor,in patients with refractory hematological malignancies显示文摘	RAVANDI F FORAN J VERSTOVSEK S	2007	Blood2007，110，11：	1
14	Clinical features of De Novo acute myeloid leukemia with concurrent DNMT3A,FLT3 and NPM 1 mutations 显示文摘	Loghavi S Zuo Z Ravandi F	2014	Hematol Oncol2014，7，1：	1
15	Conformal coating of yarns and wires with electro- spun nanofibers显示文摘	DABIRIAN F RAVANDI S A H HINESTROZA J P	2012	Polymer Engineering and Science2012，52，8：	1
16	Manufacturing of twisted continuous PAN nanofiber yarn by electrospinning process 显示文摘	DABIRIAN F RAVANDI S A H SANATGAR R H	2011	Fibers and Poly- mers2011，12，5：	1
17	Intensive chemotherapy does not benefit most older patients (age 70 years or older) with acute myeloid leukemia 显示文摘	Kantarjian H Ravandi F O'Brien S	2010	Blood2010，116，22：	1
18	First report of phase 2study of dasatinib with hyper-CVAD for the frontline treatment of patients with Philadelphia chromosome-positive(Ph1)acute lymphoblastic leukemia显示文摘	Ravandi F O'Brien S Thomas D	2010	Blood2010，116，：	1
19	Conformal coating of yarns and wires with electrospun nano- fibers显示文摘	DABIRIAN F RAVANDI S A H HINESTROZA J	2012	Polymer Engineering & Science2012，52，8：	1
20	The JAK-STATpathway : a therapeutic target in hematological malignancies显示文摘	Ferrajoli A Faderl S Ravandi F	2006	Curr Cancer Drug Targets2006，6，8：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示